How many insider trades does FilingIQ track for TVRD?

FilingIQ tracks 24 Form 4 insider transactions for TVRD (Tvardi Therapeutics, Inc.), covering filings from Apr 15, 2025 onwards. 5 of those were filed in the last 90 days.

Are TVRD insiders net buyers or net sellers?

Across the full Form 4 history for TVRD, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does TVRD insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is TVRD in?

Tvardi Therapeutics, Inc. (TVRD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $33.16M.

TVRD insider trading

Healthcare

Tvardi Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 0%

Market cap

$33.16M

About Tvardi Therapeutics, Inc.

Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in pre-clinical stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in Sugar Land, Texas.

Company website: tvarditherapeutics.com

TVRD insider activity at a glance

FilingIQ has scored 24 insider transactions for TVRD since Apr 15, 2025. The most recent filing in our index is dated Jun 9, 2026.

Across the full history, 0 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

View live TVRD trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,223

UNITED THERAPEUTICS Corp

APLS 275

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

GH 152

Guardant Health, Inc.

KalVista Pharmaceuticals, Inc.

KNSA 129

Kiniksa Pharmaceuticals International, plc

Frequently asked

How many insider trades does FilingIQ track for TVRD?: FilingIQ tracks 24 Form 4 insider transactions for TVRD (Tvardi Therapeutics, Inc.), covering filings from Apr 15, 2025 onwards. 5 of those were filed in the last 90 days.
Are TVRD insiders net buyers or net sellers?: Across the full Form 4 history for TVRD, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TVRD insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is TVRD in?: Tvardi Therapeutics, Inc. (TVRD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $33.16M.

Methodology & sources

Every TVRD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.